Can Remeron (mirtazapine) be taken with Cymbalta (duloxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Remeron (Mirtazapine) Be Taken with Cymbalta (Duloxetine)?

Yes, mirtazapine and duloxetine can be taken together, but this combination requires careful monitoring for serotonin syndrome, particularly during treatment initiation and dose adjustments. 1

Key Safety Considerations

Serotonin Syndrome Risk

The primary concern when combining these medications is serotonin syndrome, as both drugs have serotonergic activity. 1 The FDA drug label for mirtazapine explicitly lists SNRIs (including duloxetine) as "Other Serotonergic Drugs" that increase this risk. 1

Monitor patients specifically for:

  • Mental status changes (agitation, confusion, delirium) 2
  • Neuromuscular abnormalities (tremor, clonus, hyperreflexia, muscle rigidity) 2
  • Autonomic hyperactivity (hypertension, tachycardia, diaphoresis, diarrhea) 2
  • Advanced symptoms requiring immediate medical attention: fever, seizures, arrhythmias, unconsciousness 2

Clinical Evidence for Combination Therapy

The combination has been studied and used in clinical practice, particularly for treatment-resistant depression. 3, 4 However, the evidence shows mixed results:

  • A large randomized controlled trial (n=480) found that adding mirtazapine to SSRIs/SNRIs produced only a modest, non-clinically significant reduction in depression scores (-1.83 points on BDI-II at 12 weeks, p=0.087) 3
  • An observational study of 32 patients with persistent depression showed 50% response rates at 8 weeks and 56% at 6 months when combining mirtazapine with venlafaxine (another SNRI) 4
  • A comparative study found both drugs effective as monotherapy, with mirtazapine showing superior HRSD score reduction compared to duloxetine 5

Practical Management Algorithm

Starting the Combination

  1. Begin with low doses of the second agent when adding to established therapy 1
  2. Increase doses slowly with careful monitoring, especially in the first 24-48 hours after any dosage change 2
  3. Educate patients about serotonin syndrome symptoms and instruct them to seek immediate care if symptoms develop 2

Monitoring Schedule

  • First 24-48 hours after initiation or dose changes: Most critical period for serotonin syndrome 2
  • First 4 weeks: Weekly assessment for efficacy and adverse effects 2
  • Ongoing: Regular follow-up every few weeks initially 2

Expected Adverse Effects

Common side effects with this combination include: 3, 4

  • Sedation (19% in combination studies) 4
  • Weight gain (19%) 4
  • Nausea (more common with duloxetine) 5
  • Discontinuation due to adverse effects occurred in approximately 15% of patients 4

Drug Interaction Profile

Mirtazapine has minimal pharmacokinetic interactions with other antidepressants, as it is a weak or negligible inhibitor of CYP enzymes. 6 This makes it a safer choice for combination therapy compared to fluoxetine, paroxetine, or fluvoxamine, which have significant CYP inhibition. 6

Duloxetine is a moderate CYP2D6 inhibitor, but this is unlikely to significantly affect mirtazapine metabolism. 2, 6

When This Combination May Be Appropriate

Consider this combination specifically for:

  • Treatment-resistant depression after adequate trials of monotherapy 3, 4
  • Patients requiring both noradrenergic/serotonergic effects (from duloxetine) and additional histaminergic/alpha-2 antagonism (from mirtazapine) 2
  • Patients with comorbid pain conditions where duloxetine's analgesic properties are beneficial 2
  • Patients needing appetite stimulation or sleep improvement in addition to antidepressant effects, as mirtazapine promotes sleep, appetite, and weight gain 2

Critical Contraindications

Do not combine if the patient is taking:

  • MAOIs (absolute contraindication) 1
  • Multiple other serotonergic agents (tramadol, triptans, fentanyl, lithium, amphetamines, St. John's Wort) without extreme caution 1

Bottom Line

The combination is pharmacologically feasible and has been used successfully in clinical practice, but the evidence for superior efficacy over monotherapy is limited. 3 The decision should weigh the modest potential benefit against the increased risk of adverse effects, particularly serotonin syndrome, sedation, and weight gain. 3, 4 Close monitoring during initiation and dose adjustments is mandatory. 2, 1

References

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Research

Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.

Health technology assessment (Winchester, England), 2018

4
Research

Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.

Journal of psychopharmacology (Oxford, England), 2007

Related Questions

Can a patient use mirtazapine and duloxetine (Cymbalta) together?
Can mirtazapine and escitalopram (selective serotonin reuptake inhibitor (SSRI)) be given together to an adult patient with treatment-resistant depression?
Can I combine mirtazapine and propranolol (beta blocker) for treatment?
Can mirtazapine, atenolol, and buspirone be given together?
Is it safe to take duloxetine and mirtazapine together?
What is the recommended benzodiazepine protocol for managing alcohol withdrawal, including symptom‑triggered dosing based on CIWA‑Ar, taper schedule, alternatives for severe withdrawal or hepatic impairment, and adjunctive care?
What is the appropriate first‑line antibiotic and dosing for an adult with end‑stage renal disease on thrice‑weekly hemodialysis who develops acute bacterial sinusitis?
Is cefalexin (Keflex) appropriate for prophylaxis of a cat bite wound?
In a 19‑year‑old transgender woman (assigned male at birth) with baseline male‑range total testosterone, thick facial hair, and normal erectile function, who is on estradiol and spironolactone and now has fluctuating testosterone levels with loss of nocturnal erections, how should anti‑androgen therapy be adjusted to achieve consistent testosterone suppression while preserving desired sexual function?
How is polycystic ovary syndrome (PCOS) diagnosed in a woman of reproductive age?
A 30-year-old with two self-limited acute knee arthritis episodes three months apart, hemodynamically stable, no systemic features, high-normal serum uric acid (~400 µmol/L) and mildly elevated urea, which is the most likely diagnosis: gout, pseudogout, reactive arthritis, or septic arthritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question